Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
jueves, noviembre 05
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
AdaptHealth Corp
AHCO
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$7.29
-0.02
-0.27%
Últ. Act.: Nov 5, 8:56 AM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Ganancias:
Los beneficios de Q3 2026 se publicaron el mar nov 3rd, antes de la apertura del mercado
Conferencia telefónica:
La conferencia telefónica más reciente comenzó a las 8:30 a. m., hace 2 días
Haz clic para ver el webcast
AdaptHealth Financials
AdaptHealth (AHCO) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
AdaptHealth Raises FY2026 Sales Guidance from $2.850B-$2.890B to $2.880B-$2.900B vs $2.955B Est
AdaptHealth (NASDAQ:AHCO) raises FY2026 sales outlook from $2.850 billion-$2.890 billion to $2.880 billion-$2.900 billion vs $2.955 billion estimate.
Benzinga Newsdesk
PRO
AdaptHealth Q3 Sales $745.648M Miss $746.446M Estimate
AdaptHealth (NASDAQ:AHCO) reported quarterly sales of $745.648 million which missed the analyst consensus estimate of $746.446 million by 0.11 percent. This is a 9.10 percent decrease over sales of $820.314 million the
Benzinga Newsdesk
PRO
UPDATE: AdaptHealth Q2 Adj. EPS $0.08 Misses $0.17 Estimate
AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.17 by 52.94 percent. This is a 20 percent decrease over earnings of $0.10 per share from the
Benzinga Newsdesk
PRO
AdaptHealth Lowers FY2026 Sales Guidance from $3.450B-$3.520B to $2.850B-$2.890B vs $3.488B Est
AdaptHealth (NASDAQ:AHCO) lowers FY2026 sales outlook from $3.450 billion-$3.520 billion to $2.850 billion-$2.890 billion vs $3.488 billion estimate.
Benzinga Newsdesk
PRO
AdaptHealth Q2 EPS $(0.99) Misses $0.18 Estimate, Sales $740.300M Miss $848.627M Estimate
AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of $0.18 by 650 percent. This is a 1090 percent decrease over earnings of $0.10 per share from the
Benzinga Newsdesk
PRO
CORRECTION: AdaptHealth Q1 Adj. EPS $(0.05) Misses $0.02 Estimate, Sales $819.799M Beat $796.621M Estimate
AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.02 by 350 percent. This is unchanged from the same period last year. The company reported
Benzinga Newsdesk
